ÂÜÀòÂÒÂ×

Danielle Curcio has a wealth of experience in the pharmaceutical industry. Danielle began their career in 2007 as a Regulatory Affairs Specialist at Givaudan. In the same year, they also began working at The Medicines Company as a Clinical Trials Associate and Clinical Trial Coordinator. From 2011 to 2015, they worked at Omthera Pharmaceuticals, Inc. as a Project Manager, Clinical Development. Danielle then moved to Regeneron Pharmaceuticals, Inc. in 2015 as a Clinical Trial Manager. In 2017, they returned to The Medicines Company as a Clinical Project Director. In 2020, they began working at Novartis as a Sr. Clinical Project Director and in 2021, they began working at NewAmsterdam Pharma as an Executive Director, Clinical Operations and a Senior Director, Clinical Operations.

Danielle Curcio completed their Master of Business Administration (MBA) in Management from Centenary University in 2012. Prior to that, they earned a BS in Biology and Chemistry from Sacred Heart University in 2007.